M&T Bank Corp Sells 137 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

M&T Bank Corp cut its stake in Church & Dwight Co., Inc. (NYSE:CHD – Get Rating) by 0.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 141,477 shares of the company’s stock after selling 137 shares during the quarter. M&T Bank Corp owned about 0.06% of Church & Dwight worth $10,107,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. SeaCrest Wealth Management LLC bought a new stake in shares of Church & Dwight during the second quarter worth $30,000. Old North State Trust LLC bought a new stake in shares of Church & Dwight during the third quarter worth $30,000. Guardian Wealth Advisors LLC bought a new stake in shares of Church & Dwight during the third quarter worth $34,000. Pin Oak Investment Advisors Inc. bought a new stake in shares of Church & Dwight during the second quarter worth $37,000. Finally, Asset Dedication LLC bought a new stake in shares of Church & Dwight during the third quarter worth $43,000. 80.86% of the stock is currently owned by institutional investors.

Church & Dwight Price Performance

Shares of CHD stock opened at $86.19 on Thursday. Church & Dwight Co., Inc. has a fifty-two week low of $70.16 and a fifty-two week high of $105.28. The firm has a market capitalization of $21.03 billion, a price-to-earnings ratio of 51.30, a PEG ratio of 3.57 and a beta of 0.45. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.63 and a current ratio of 1.18. The stock’s 50-day simple moving average is $82.89 and its 200-day simple moving average is $79.38.

Church & Dwight (NYSE:CHD – Get Rating) last issued its quarterly earnings results on Friday, February 3rd. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.60 by $0.02. Church & Dwight had a return on equity of 20.70% and a net margin of 7.70%. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the previous year, the firm earned $0.64 earnings per share. The company’s revenue was up 4.9% on a year-over-year basis. As a group, equities analysts forecast that Church & Dwight Co., Inc. will post 3.08 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 1st. Stockholders of record on Wednesday, February 15th were paid a dividend of $0.2725 per share. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.26. The ex-dividend date was Tuesday, February 14th. This represents a $1.09 dividend on an annualized basis and a dividend yield of 1.26%. Church & Dwight’s payout ratio is presently 64.88%.

Insider Transactions at Church & Dwight

In other news, EVP Paul Richard Wood sold 48,262 shares of the business’s stock in a transaction dated Wednesday, March 8th. The stock was sold at an average price of $83.37, for a total transaction of $4,023,602.94. Following the sale, the executive vice president now owns 120 shares in the company, valued at $10,004.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Paul Richard Wood sold 48,262 shares of Church & Dwight stock in a transaction dated Wednesday, March 8th. The stock was sold at an average price of $83.37, for a total transaction of $4,023,602.94. Following the completion of the sale, the executive vice president now owns 120 shares of the company’s stock, valued at $10,004.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ravichandra Krishnamu Saligram sold 17,544 shares of Church & Dwight stock in a transaction dated Friday, March 10th. The stock was sold at an average price of $84.00, for a total value of $1,473,696.00. Following the sale, the director now directly owns 33,835 shares of the company’s stock, valued at approximately $2,842,140. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 83,350 shares of company stock worth $6,969,241. Insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Argus downgraded Church & Dwight from a “buy” rating to a “hold” rating in a research report on Monday, February 13th. Atlantic Securities upgraded Church & Dwight from an “underweight” rating to a “neutral” rating and set a $80.00 price target on the stock in a research note on Monday, February 6th. Wells Fargo & Company raised their price target on Church & Dwight from $82.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, January 3rd. Oppenheimer restated an “outperform” rating and set a $93.00 price target on shares of Church & Dwight in a research note on Tuesday, February 7th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Church & Dwight from $90.00 to $91.00 and gave the company a “buy” rating in a research note on Monday, February 6th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Church & Dwight currently has an average rating of “Hold” and an average target price of $87.81.

Church & Dwight Profile

(Get Rating)

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.